RBRKJuly 20, 2026 at 9:27 PM UTCSoftware & Services

Rubrik's Bullish Narrative Persists, But DeepValue Warns on Valuation and Missing Proof

Read source article

What happened

A new Seeking Alpha article touts Rubrik's compelling value at 31x next year's free cash flow, driven by 28% y/y revenue growth and management's guidance to $515M free cash flow by FY2028. While the article echoes the market's enthusiasm for the AI and identity resilience expansion, the DeepValue report maintains a WAIT rating, emphasizing that the current price of ~$87 already prices in a successful platform transition. The report highlights persistent concerns: quarterly SBC of $73M, a $975M unrecognized RSU overhang, and the lack of disclosed revenue contribution from AI and identity products. Additionally, the Q1 FY27 benefit from non-recurring Subscription Credits (~$8.5M) will fade, creating a headwind to reported growth. Thus, while the article's bullish narrative is not wrong, it does not provide the concrete proof needed to upgrade the rating from cautious to confident.

Implication

The article's bullish thesis is already priced into the stock at 31x next year's FCF, offering no margin of safety. The DeepValue report underscores that heavy dilution (quarterly SBC of $73M and rising share count) and cloud cost pressure will likely constrain per-share value creation. Until we see subscription ARR exit within the raised FY27 guidance, sustained gross margin above 80%, and explicit metrics for AI and identity products, the risk/reward remains unfavorable. A better entry would be near the attractive price of $78 or after two quarters of demonstrable cross-sell execution. For now, patience is the prudent course, as the narrative outpaces the data.

Thesis delta

The article reinforces the bull case that Rubrik is executing well and offers attractive FCF multiples, but it does not provide new evidence that changes the DeepValue thesis. The core hold is that current price already anticipates a successful platform expansion without proof. Therefore, the recommended stance remains 'WAIT' until either a cheaper entry or demonstrable cross-sell momentum emerges.

Confidence

moderate